Copyright Reports & Markets. All rights reserved.

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 IBS-D Drugs
      • 1.4.3 IBS-C Drugs
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Application (2019-2025)
      • 1.5.2 Women
      • 1.5.3 Men
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size
    • 2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Growth Trends by Regions
      • 2.2.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by by Players
      • 3.1.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Area Served
    • 3.3 Key Players Rx Irritable Bowel Syndrome (IBS) Drugs Product/Solution/Service
    • 3.4 Date of Enter into Rx Irritable Bowel Syndrome (IBS) Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2014-2019)
    • 4.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2014-2019)
    • 5.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in North America
    • 5.3 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
    • 5.4 North America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2014-2019)
    • 6.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Europe
    • 6.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
    • 6.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application

    7 China

    • 7.1 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2014-2019)
    • 7.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in China
    • 7.3 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
    • 7.4 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2014-2019)
    • 8.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Japan
    • 8.3 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
    • 8.4 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2014-2019)
    • 9.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
    • 9.4 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application

    10 India

    • 10.1 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2014-2019)
    • 10.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in India
    • 10.3 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
    • 10.4 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size (2014-2019)
    • 11.2 Rx Irritable Bowel Syndrome (IBS) Drugs Key Players in Central & South America
    • 11.3 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
    • 11.4 Central & South America Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Ironwood Pharmaceuticals
      • 12.1.1 Ironwood Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
      • 12.1.4 Ironwood Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2014-2019))
      • 12.1.5 Ironwood Pharmaceuticals Recent Development
    • 12.2 Bausch Health
      • 12.2.1 Bausch Health Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
      • 12.2.4 Bausch Health Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2014-2019)
      • 12.2.5 Bausch Health Recent Development
    • 12.3 Takeda
      • 12.3.1 Takeda Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
      • 12.3.4 Takeda Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2014-2019)
      • 12.3.5 Takeda Recent Development
    • 12.4 Sebela Pharmaceuticals
      • 12.4.1 Sebela Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
      • 12.4.4 Sebela Pharmaceuticals Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2014-2019)
      • 12.4.5 Sebela Pharmaceuticals Recent Development
    • 12.5 Allergan
      • 12.5.1 Allergan Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Rx Irritable Bowel Syndrome (IBS) Drugs Introduction
      • 12.5.4 Allergan Revenue in Rx Irritable Bowel Syndrome (IBS) Drugs Business (2014-2019)
      • 12.5.5 Allergan Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Rx Irritable Bowel Syndrome (IBS) Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rx Irritable Bowel Syndrome (IBS) Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Ironwood Pharmaceuticals
      Bausch Health
      Takeda
      Sebela Pharmaceuticals
      Allergan
      ...

      Market segment by Type, the product can be split into
      IBS-D Drugs
      IBS-C Drugs
      Others

      Market segment by Application, split into
      Women
      Men

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Rx Irritable Bowel Syndrome (IBS) Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Rx Irritable Bowel Syndrome (IBS) Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Rx Irritable Bowel Syndrome (IBS) Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now